+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intravenous Iron Drugs Market by Drug Type (Ferric Carboxymaltose, Ferumoxytol, Iron Dextran), Indication (Cancer-Associated Anemia, Chronic Kidney Disease, Iron Deficiency Anemia), End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2030- Product Image
Intravenous Iron Drugs Market by Drug Type (Ferric Carboxymaltose, Ferumoxytol, Iron Dextran), Indication (Cancer-Associated Anemia, Chronic Kidney Disease, Iron Deficiency Anemia), End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2030- Product Image
Sale

Intravenous Iron Drugs Market by Drug Type (Ferric Carboxymaltose, Ferumoxytol, Iron Dextran), Indication (Cancer-Associated Anemia, Chronic Kidney Disease, Iron Deficiency Anemia), End User, Distribution Channel, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5454933
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global intravenous iron drugs market is undergoing a significant transformation, driven by advancements in therapy options, regulatory shifts, and changing patient care models. As health systems move toward value-based treatment and personalized medicine, senior leaders must navigate evolving drug innovations, tariff impacts, and expanding patient demographics to optimize their strategies.

Market Snapshot: Intravenous Iron Drugs Market Growth and Outlook

The Intravenous Iron Drugs Market grew from USD 3.16 billion in 2024 to USD 3.47 billion in 2025. It is expected to continue growing at a CAGR of 9.68%, reaching USD 5.51 billion by 2030. This forecast underscores sustained demand across chronic kidney disease care, oncology, pregnancy-related anemia, and broader anemia management. Ongoing innovation in drug formulations and evolving clinical protocols point to continued expansion, with emerging regions playing a key role in market acceleration.

Scope & Segmentation: Comprehensive Intravenous Iron Therapy Landscape

This report provides a detailed breakdown of the intravenous iron drugs market, capturing the breadth of therapeutic approaches, end-user settings, and global regions. Segmentation ensures concrete commercial insights for stakeholders.

  • Drug Types: Ferric carboxymaltose, ferumoxytol, iron dextran, iron isomaltoside, iron sucrose
  • Indications: Cancer-associated anemia, chronic kidney disease (hemodialysis, peritoneal dialysis, predialysis), iron deficiency anemia, pregnancy-related anemia
  • End Users: Dialysis centers, hospitals, specialty clinics
  • Distribution Channels: Hospital pharmacies, online pharmacies, retail pharmacies
  • Patient Age Groups: Adult, geriatric, pediatric
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific

Segmenting the market by these key drivers allows for more targeted competitive and operational planning, and highlights where specific treatment innovations align with clinical and commercial opportunities worldwide.

Key Takeaways for Senior Decision Makers

  • IV iron therapies are increasingly preferred where rapid iron repletion and improved patient compliance are critical, shaping new standards of care in chronic disease management.
  • Recent technological innovations in iron complex formulations have reduced immunogenicity and adverse reactions, enabling outpatient and decentralized infusion models that meet modern healthcare delivery needs.
  • Manufacturers are intensifying investment in pipeline diversification, including novel iron-carbohydrate complexes suited to resistant forms of anemia and combination therapies for broad-spectrum applicability.
  • Evolving reimbursement structures and value-based care initiatives are influencing product positioning, with evidence of reduced hospital stays and transfusions becoming central to adoption and payer negotiations.
  • Digital health solutions—such as real-time outcome monitoring and remote infusion oversight—are facilitating therapy expansion into rural and under-served markets while enhancing patient safety and adherence.

Tariff Impact: U.S. Tariffs Reshape Global Supply Chains

The introduction of cumulative United States tariffs in 2025 on critical pharmaceutical ingredients such as active iron salts and specialized ligands has prompted a realignment of supply and production strategies. Companies are adapting via local manufacturing expansion and alternative sourcing to mitigate cost pressures, while closely monitoring quality assurance and regulatory documentation. These changes are influencing inventory management and budget allocations for hospitals and specialty infusion centers, particularly as organizations look to minimize downstream disruptions and adapt procurement in the face of evolving policy landscapes.

Competitive Landscape & Regional Dynamics

Industry leaders, including Vifor Pharma Ltd., Luitpold Pharmaceuticals, Pharmacosmos A/S, Fresenius Kabi AG, and others, are navigating complex regulatory environments through strategic M&A, digital platform integration, and expansion of geographic footprints. Collaboration with healthcare providers and manufacturing alliances helps to address local regulatory pathways, optimize logistics, and enhance responsiveness to market-specific drivers in both developed and high-growth emerging economies.

Methodology & Data Sources

Analysis is based on a multi-layered research model, incorporating in-depth interviews with clinical experts and procurement specialists. Secondary sources include regulatory filings, peer-reviewed clinical studies, patents, and validated industry publications. Findings are cross-checked through quantitative datasets and subject matter workshops to ensure accuracy and contextual relevance across segments and global markets.

Why This Report Matters for Executive Strategy

  • Enables informed decision-making by contextualizing regional disparities, innovation trajectories, and regulatory shifts in the intravenous iron drugs market.
  • Helps optimize product portfolios and market entry planning by aligning with clinical drivers, demographic needs, and emerging supply chain imperatives.

Conclusion

The intravenous iron drugs market presents expanding opportunity for value-driven growth, innovation, and operational efficiency. Stakeholders who adapt to new therapeutic, regulatory, and competitive dynamics are positioned to achieve long-term success in diverse treatment settings.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of novel intravenous iron formulations with reduced infusion times and improved safety profiles driving adoption in outpatient settings
5.2. Expansion of intravenous iron use in chronic kidney disease protocols following updated nephrology guidelines highlighting anemia management
5.3. Growing integration of intravenous iron therapies in oncology supportive care to mitigate chemotherapy induced anemia and improve patient outcomes
5.4. Strategic partnerships between pharmaceutical companies and health systems to enhance iron deficiency screening and intravenous iron administration programs
5.5. Rising demand for ready to use intravenous iron preparations in hospital pharmacies due to simplified dosing and reduced preparation errors
5.6. Increased focus on patient reported outcomes and quality of life metrics in clinical trials evaluating new intravenous iron compounds
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Intravenous Iron Drugs Market, by Drug Type
8.1. Introduction
8.2. Ferric Carboxymaltose
8.3. Ferumoxytol
8.4. Iron Dextran
8.5. Iron Isomaltoside
8.6. Iron Sucrose
9. Intravenous Iron Drugs Market, by Indication
9.1. Introduction
9.2. Cancer-Associated Anemia
9.3. Chronic Kidney Disease
9.3.1. Hemodialysis
9.3.2. Peritoneal Dialysis
9.3.3. Predialysis
9.4. Iron Deficiency Anemia
9.5. Pregnancy-Related Anemia
10. Intravenous Iron Drugs Market, by End User
10.1. Introduction
10.2. Dialysis Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Intravenous Iron Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Intravenous Iron Drugs Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Intravenous Iron Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Intravenous Iron Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Intravenous Iron Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Vifor Pharma Ltd.
16.3.2. Luitpold Pharmaceuticals, LLC
16.3.3. Pharmacosmos A/S
16.3.4. Fresenius Kabi AG
16.3.5. Baxter International Inc.
16.3.6. American Regent, Inc.
16.3.7. Nipro Corporation
16.3.8. Dr. Falk Pharma GmbH
16.3.9. Teva Pharmaceutical Industries Ltd.
16.3.10. Sanofi S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INTRAVENOUS IRON DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. INTRAVENOUS IRON DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. INTRAVENOUS IRON DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. INTRAVENOUS IRON DRUGS MARKET: RESEARCHAI
FIGURE 26. INTRAVENOUS IRON DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. INTRAVENOUS IRON DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. INTRAVENOUS IRON DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INTRAVENOUS IRON DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY FERUMOXYTOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY FERUMOXYTOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON DEXTRAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON DEXTRAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON ISOMALTOSIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON ISOMALTOSIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON SUCROSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON SUCROSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CANCER-ASSOCIATED ANEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CANCER-ASSOCIATED ANEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREDIALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREDIALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON DEFICIENCY ANEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY IRON DEFICIENCY ANEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PREGNANCY-RELATED ANEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 91. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 96. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 97. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. CANADA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 114. MEXICO INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 165. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 166. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 167. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 170. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 171. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 176. GERMANY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 177. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 178. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 179. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 182. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 183. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. FRANCE INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 201. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 202. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 203. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 206. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 207. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 212. ITALY INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 213. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 214. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 215. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 218. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 219. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 224. SPAIN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. SOUTH AFRICA INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 262. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 263. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 266. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 267. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 272. DENMARK INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 285. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 286. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 287. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 290. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 291. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 296. QATAR INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 297. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 298. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 299. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 302. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 303. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 308. FINLAND INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 320. SWEDEN INTRAVENOUS IRON DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA INTRAVENOUS IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, 2018-2024 (US

Samples

Loading
LOADING...

Companies Mentioned

  • Vifor Pharma Ltd.
  • Luitpold Pharmaceuticals, LLC
  • Pharmacosmos A/S
  • Fresenius Kabi AG
  • Baxter International Inc.
  • American Regent, Inc.
  • Nipro Corporation
  • Dr. Falk Pharma GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.51 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Iron Drugs Market by Drug Type (Intravenous, Oral), Indication (Chronic Kidney Disease, Heavy Menstrual Bleeding, Iron Deficiency Anemia), Distribution Channel, End User, Formulation - Global Forecast 2025-2030 - Product Image

Iron Drugs Market by Drug Type (Intravenous, Oral), Indication (Chronic Kidney Disease, Heavy Menstrual Bleeding, Iron Deficiency Anemia), Distribution Channel, End User, Formulation - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Intravenous Iron Drugs Market Size, Share, & Trends Analysis Report by Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose), Application (Chronic Kidney Disease), and Region with Growth Forecasts, 2025-2030 - Product Image

Intravenous Iron Drugs Market Size, Share, & Trends Analysis Report by Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose), Application (Chronic Kidney Disease), and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Intravenous Iron Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Intravenous Iron Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 81 Pages
  • Global
From
Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • 354 Pages
  • Global
From
Intravenous Iron Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Intravenous Iron Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Intravenous Iron Market

The Intravenous Iron market is a segment of the Hematological Drugs market, which includes drugs used to treat anemia and other blood disorders. Intravenous Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough iron to produce healthy red blood cells. Intravenous Iron is administered directly into the bloodstream, allowing for a more rapid increase in iron levels than oral iron supplements. Intravenous Iron is used in a variety of settings, including hospitals, clinics, and home care. It is often prescribed to patients who are unable to take oral iron supplements due to gastrointestinal issues or who require a more rapid increase in iron levels. The Intravenous Iron market is highly competitive, with a number of companies offering products in this space. Some of the major players in the market include Vifor Pharma, Fresenius Kabi, American Regent, and B. Braun. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.